DK1075471T3 - Idolylderivater som serotonerge midler - Google Patents

Idolylderivater som serotonerge midler

Info

Publication number
DK1075471T3
DK1075471T3 DK99918860T DK99918860T DK1075471T3 DK 1075471 T3 DK1075471 T3 DK 1075471T3 DK 99918860 T DK99918860 T DK 99918860T DK 99918860 T DK99918860 T DK 99918860T DK 1075471 T3 DK1075471 T3 DK 1075471T3
Authority
DK
Denmark
Prior art keywords
idolyl
derivatives
serotonergic agents
serotonergic
agents
Prior art date
Application number
DK99918860T
Other languages
Danish (da)
English (en)
Inventor
Michael Gerard Kelly
Young Hee Kang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1075471T3 publication Critical patent/DK1075471T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99918860T 1998-04-29 1999-04-28 Idolylderivater som serotonerge midler DK1075471T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6904598A 1998-04-29 1998-04-29
EP99918860A EP1075471B1 (de) 1998-04-29 1999-04-28 Indolderivate als serotonergische mittel

Publications (1)

Publication Number Publication Date
DK1075471T3 true DK1075471T3 (da) 2005-01-17

Family

ID=22086373

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99918860T DK1075471T3 (da) 1998-04-29 1999-04-28 Idolylderivater som serotonerge midler

Country Status (13)

Country Link
EP (1) EP1075471B1 (de)
JP (1) JP2002513015A (de)
CN (1) CN1144800C (de)
AR (1) AR015037A1 (de)
AT (1) ATE282606T1 (de)
AU (1) AU3667699A (de)
CA (1) CA2330436A1 (de)
DE (1) DE69921983T2 (de)
DK (1) DK1075471T3 (de)
ES (1) ES2232132T3 (de)
PT (1) PT1075471E (de)
TW (1) TW528754B (de)
WO (1) WO1999055694A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291646B2 (en) 1999-11-24 2007-11-06 Wyeth Ethers of O-desmethyl venlafaxine
WO2003006455A1 (en) * 2001-07-11 2003-01-23 Eli Lilly And Company Pharmaceutical compounds with serotonin receptor activity
US7414052B2 (en) * 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) * 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US20070072897A1 (en) * 2005-09-29 2007-03-29 Wyeth Phenylaminopropanol derivatives and methods of their use
US9232959B2 (en) 2007-01-02 2016-01-12 Aquabeam, Llc Multi fluid tissue resection methods and devices
JP5506702B2 (ja) 2008-03-06 2014-05-28 アクアビーム エルエルシー 流体流れ内を伝達される光学エネルギーによる組織切除および焼灼
US9848904B2 (en) 2009-03-06 2017-12-26 Procept Biorobotics Corporation Tissue resection and treatment with shedding pulses
JP6080872B2 (ja) 2012-02-29 2017-02-15 プロセプト バイオロボティクス コーポレイション 自動化された画像誘導組織切除および治療
CN105431096B (zh) 2013-02-14 2018-07-31 普罗赛普特生物机器人公司 液体消融液体束眼外科手术的方法和装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA954689B (en) * 1994-06-08 1996-01-29 Lundbeck & Co As H 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
TW421649B (en) * 1995-01-31 2001-02-11 Janssen Pharmaceutica Nv 4-(1H-indol-1yl)-1-piperidinyl derivatives
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
EP1075471A1 (de) 2001-02-14
ATE282606T1 (de) 2004-12-15
CN1144800C (zh) 2004-04-07
ES2232132T3 (es) 2005-05-16
EP1075471B1 (de) 2004-11-17
TW528754B (en) 2003-04-21
CN1307574A (zh) 2001-08-08
DE69921983D1 (de) 2004-12-23
DE69921983T2 (de) 2005-04-07
AR015037A1 (es) 2001-04-11
CA2330436A1 (en) 1999-11-04
PT1075471E (pt) 2005-02-28
JP2002513015A (ja) 2002-05-08
WO1999055694A1 (en) 1999-11-04
AU3667699A (en) 1999-11-16

Similar Documents

Publication Publication Date Title
NO20015477D0 (no) 4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
NO20011738D0 (no) Heterocyclylaminometyloksazolidinoner som antibakterielle midler
DK1028961T3 (da) Pleuromutilinderivater som antimikrobielle midler
NO20014412L (no) Forbindelser nyttige som anti-inflammatoriske midler
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
DE69930518D1 (de) Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate
NO20006071D0 (no) Isotiazolderivater nyttige som anti-cancer midler
DK0802184T3 (da) N-Benzyl-2-phenylindoler som østrogene midler
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
NO20013559D0 (no) Aromatiske heterocykliske forbindelser som anti- inflammatoriske midler
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
NO20013860L (no) 16-hydroksyöstratriener som selektive östrogener
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
DK1075471T3 (da) Idolylderivater som serotonerge midler
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
NO20000434D0 (no) Lyksofuranosyl benzimidazoler som antivirale midler
TR200002831A3 (tr) Kinolin-4-Il türevleri I
ID28198A (id) Derivatip-derivatip arilpiperazin yang berguna sebagai penghalang uroselektif alfa-1 adrenoseptor
DK1073651T3 (da) Indolylderivater som serotonerge midler
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
FI980053A0 (fi) Anordning foer utformande av fiberbollar av laongstraeckta fibrer som foeljer med enluftstroem
NO20013640D0 (no) 3,6-disubstituerte penamsufon-derivater som antibakterielle midler
FI980755A0 (fi) Foerfarande foer montering/faestande av vaermeisoleringsskivor som vaermeisolering i en byggnad